Feasibility and Safety of Anlotinib Combined with Immune Checkpoint Inhibitors in Patients with Previously Immunotherapy-Treated Extensive-Stage Small Cell Lung Cancer: A Retrospective Exploratory Study - Chen TF; Li ZJ; Zhao HS; Yang R (Drug Design, Development and Therapy, 2025)